ORALLY DISINTEGRATING DOSAGE FORMS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20070292508A1
SERIAL NO

11754507

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to orally disintegrating dosage forms comprising lipid coated substrates and silicified excipients. The use of silicified excipients in the orally disintegrating dosage form along with lipid coating of active agents, allows for improvements in the ability to prepare these dosage forms. Further, the dosage form can prevent unpleasant taste or aftertaste and provide better chemical and mechanical stability of the coated active substrate. This present invention also provides the possibility of harder more durable tablets, along with targeted immediate or modified release profiles for the active agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BALCHEM CORPORATION52 SUNRISE PARK ROAD NEW HAMPTON NY 10958

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Richardson, Paul H Vernon, NJ 14 439
Szamosi, Janos Greentown, PA 11 81
Yu, Liangping Mahwah, NJ 3 76

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation